GROUP ONE TRADING, L.P. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515901. A total of 5 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$44,000
-21.4%
12,900
-12.8%
0.00%
Q2 2018$56,000
-60.0%
14,800
-56.7%
0.00%
-100.0%
Q1 2018$140,000
-61.1%
34,200
-55.9%
0.00%
-66.7%
Q4 2017$360,000
+221.4%
77,500
+390.5%
0.00%
+200.0%
Q3 2017$112,000
-80.6%
15,800
-80.2%
0.00%
-83.3%
Q2 2017$576,000
+33.0%
79,700
+13.4%
0.01%
+20.0%
Q1 2017$433,000
-55.3%
70,300
-57.5%
0.01%
-44.4%
Q4 2016$969,000
-31.0%
165,400
-37.4%
0.01%
-40.0%
Q3 2016$1,404,000
+21.8%
264,400
+51.8%
0.02%
+7.1%
Q2 2016$1,153,000
+209.1%
174,200
+118.3%
0.01%
+180.0%
Q1 2016$373,000
-55.0%
79,800
-51.4%
0.01%
-50.0%
Q4 2015$829,000
+9.9%
164,200
-23.3%
0.01%0.0%
Q3 2015$754,000
-45.6%
214,100
+54.0%
0.01%
-47.4%
Q2 2015$1,387,000
+234.2%
139,000
+326.4%
0.02%
+171.4%
Q1 2015$415,000
-74.7%
32,600
-71.9%
0.01%
-72.0%
Q4 2014$1,640,000
-47.2%
115,900
-48.7%
0.02%
-47.9%
Q3 2014$3,108,000
+29.9%
226,000
+45.3%
0.05%
+29.7%
Q2 2014$2,392,000
-73.6%
155,500
-70.8%
0.04%
-75.7%
Q1 2014$9,060,000
+124.0%
531,700
+70.3%
0.15%
+149.2%
Q4 2013$4,044,000
+30.7%
312,300
+2.0%
0.06%
+3.4%
Q3 2013$3,093,000
-1.8%
306,200
-27.4%
0.06%
-24.4%
Q2 2013$3,151,000421,8000.08%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 115,900$1,640,0000.02%
SABBY MANAGEMENT, LLC 250$354,0000.01%
SIMPLEX TRADING, LLC 139$21,0000.00%
Citadel Advisors 65,500$927,0000.00%
BLAIR WILLIAM & CO/IL 3,000$42,0000.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders